Provention Bio, Inc. (2VB.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 09:15AM CET. Market open.
Currency in EUR
Valuation Measures4
| Market Cap (intraday) | 729.84M |
| Enterprise Value | 581.06M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 225.34 |
| Price/Book (mrq) | 5.53 |
| Enterprise Value/Revenue | 207.60 |
| Enterprise Value/EBITDA | -5.16 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.29 |
| 52-Week Change 3 | 117.54% |
| S&P500 52-Week Change 3 | -8.38% |
| 52 Week High 3 | 10.00 |
| 52 Week Low 3 | 3.22 |
| 50-Day Moving Average 3 | 8.60 |
| 200-Day Moving Average 3 | 5.76 |
Share Statistics
| Avg Vol (3 month) 3 | 179 |
| Avg Vol (10 day) 3 | 201 |
| Shares Outstanding 5 | 87.19M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 64.26M |
| % Held by Insiders 1 | 6.06% |
| % Held by Institutions 1 | 45.58% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in USD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2021 |
| Most Recent Quarter (mrq) | Sept 30, 2022 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -4,067.60% |
Management Effectiveness
| Return on Assets (ttm) | -40.46% |
| Return on Equity (ttm) | -76.10% |
Income Statement
| Revenue (ttm) | 2.8M |
| Revenue Per Share (ttm) | 0.04 |
| Quarterly Revenue Growth (yoy) | 11.50% |
| Gross Profit (ttm) | -68.23M |
| EBITDA | -113.3M |
| Net Income Avi to Common (ttm) | -106.12M |
| Diluted EPS (ttm) | -1.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 185.52M |
| Total Cash Per Share (mrq) | 2.13 |
| Total Debt (mrq) | 23.92M |
| Total Debt/Equity (mrq) | 16.52 |
| Current Ratio (mrq) | 7.58 |
| Book Value Per Share (mrq) | 1.66 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -90.89M |
| Levered Free Cash Flow (ttm) | -54.89M |
© 2023 Yahoo. All rights reserved.
